MedTrace Logo

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial

NCT03183804 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2023-08-25

No results posted yet for this study

Summary

This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 2 clinical trial (ALLO-ASC-DFU-201) for 23 months.

Conditions

  • Diabetic Foot Ulcer

Interventions

BIOLOGICAL

ALLO-ASC-DFU

Application of ALLO-ASC-DFU sheet to diabetic foot ulcer. This study is a follow-up study without intervention.

OTHER

Standard therapy

Standard therapy conducted for patients with diabetic foot ulcer. This study is a follow-up study without intervention.

Sponsors & Collaborators

  • Anterogen Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Seung-Kyu Han, MD. Ph D. · Korea University Guro Hospital

  • Ki-Won Young, MD. Ph D. · Eulji General Hospital

  • Hyun-suk Suh, MD. Ph D. · Asan Medical Center

  • Jin Woo Lee, MD. Ph D. · Severance Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-29
Primary Completion
2018-08-17
Completion
2018-10-24

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03183804 on ClinicalTrials.gov